Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
aspirin + dipyridamole
- Development stage
- Unknown
- Lead developer
- Boehringer Ingelheim
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
aspirin + dipyridamole is an oral combination antiplatelet therapy developed and manufactured by Hubei Biocause Pharmaceutical. It consists of two active ingredients with complementary mechanisms: aspirin and dipyridamole. Aspirin acts by irreversibly inhibiting cyclooxygenase-1 (COX-1), which prevents the formation of thromboxane A2, a key mediator in platelet aggregation. Dipyridamole inhibits the activity of phosphodiesterase (PDE), leading to increased intracellular levels of cAMP and cGMP, and also blocks the uptake of adenosine into platelets and other cells, further enhancing its antiplatelet effects. This combination is approved for the secondary prevention of ischemic stroke and transient ischemic attacks (TIA).
- Brand names
- Jinbaotong金保通
- Other names
- 阿司匹林双嘧达莫片Aspirin/dipyridamoleDipyridamole/aspirin
02
Targets
PDE (Phosphodiesterase family)ENT1 (Solute carrier family 29 member 1)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on aspirin + dipyridamole.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on aspirin + dipyridamole.